Comprehensive analysis of juvenile idiopathic arthritis patients' immune characteristics based on bulk and single-cell sequencing data

Front Mol Biosci. 2024 May 1:11:1359235. doi: 10.3389/fmolb.2024.1359235. eCollection 2024.

Abstract

Background: The pathogenesis of juvenile idiopathic arthritis (JIA) is strongly influenced by an impaired immune system. However, the molecular mechanisms underlying its development and progression have not been elucidated. In this study, the computational methods TRUST4 were used to construct a T-cell receptor (TCR) and B-cell receptor (BCR) repertoire from the peripheral blood of JIA patients via bulk RNA-seq data, after which the clonality and diversity of the immune repertoire were analyzed.

Results: Our findings revealed significant differences in the frequency of clonotypes between the JIA and healthy control groups in terms of the TCR and BCR repertoires. This work identified specific V genes and J genes in TCRs and BCRs that could be used to expand our understanding of JIA. After single-cell RNA analysis, the relative percentages of CD14 monocytes were significantly greater in the JIA group. Cell-cell communication analysis revealed the significant role of the MIF signaling pathway in JIA.

Conclusion: In conclusion, this work describes the immune features of both the TCR and BCR repertoires under JIA conditions and provides novel insight into immunotherapy for JIA.

Keywords: B-cell receptor; T-cell receptor; immune repertoire; juvenile idiopathic arthritis; single-cell RNA sequencing.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded by the Guizhou Provincial Health Commission [gzwkj2021-526, gzwkj2022–440, gzwkj2022-438, gzwkj2022-441], the Natural Science Foundation of Guizhou Province, China (Grant No. Guizhou Province-ZK [2022] General 300, Guizhou Province-performance-LC [2023]024), Zunyi Municipal Natural Science Foundation (major human resources-related program [2021] No. 8), Guizhou Aerospace Hospital (gzhtyy-2023-3).